Antioxidant drugs have been reported to protect pancreatic islets from the adverse effects of chronic exposure to supraphysiological glucose concentrations. However, glucose has not been shown to increase intracellular oxidant load in islets, nor have the effects of increasing or inhibiting glutathione peroxidase (GPx) activity on islet resistance to sugar-induced oxidant stress been studied. We observed that high glucose concentrations increased intracellular peroxide levels in human islets and the pancreatic  cell line, HIT-T15. Inhibition of ␥-glutamylcysteine synthetase (␥GCS) by buthionine sulfoximine augmented the increase in islet peroxide and decrease in insulin mRNA levels, content, and secretion in islets and HIT-T15 cells induced by ribose. Adenoviral overexpression of GPx increased GPx activity and protected islets against adverse effects of ribose. These results demonstrate that glucose and ribose increase islet peroxide accumulation and that the adverse consequences of ribose-induced oxidative stress on insulin mRNA, content, and secretion can be augmented by a glutathione synthesis inhibitor and prevented by increasing islet GPx activity. These observations support the hypothesis that oxidative stress is one mechanism for glucose toxicity in pancreatic islets. T ype 2 diabetes mellitus is polygenic in origin and usually begins in adulthood, although specific genes for subtypes of this disease that occur earlier in life, referred to collectively as maturity-onset diabetes of the young (MODY), have been identified (1). The onset of type 2 diabetes is insidious, thus hyperglycemia develops gradually and often goes untreated for years until symptoms become clinically obvious. Consequent chronic exposure of tissues to supraphysiologic levels of blood glucose can lead to adverse intracellular outcomes, a process known as glucose toxicity (2-5). Possible mechanisms of action for glucose toxicity include the formation of advanced glycosylation end products and glucosamine, increased protein kinase C activity with c-myc induction, autooxidation of glucose, and increased levels of reactive glycolytic intermediates such as glyceraldehyde-3-phosphate or dihydroxyacetone phosphate (6 -13). All these processes usually are accompanied by the formation of reactive oxygen species (ROS), setting up the potential for oxidative stress. Many weeks of exposure to high concentrations of glucose are necessary before glucotoxic effects are expressed by islet  cells in vitro and in vivo (14 -20). Because isolated islets do not reliably survive in culture greater than 2 weeks, the use of short-term exposure to ribose, a sugar that generates ROS more potently than glucose, has become an accepted model for studying islet glucose toxicity (21,22). The use of ribose as a prooxidant sugar is especially valuable in adenoviral overexpression systems, because the overexpression effect is short-lived, lasting only days.In the pancreatic  cell, glucose and ribose toxicity cause decreased insulin mRNA levels (14-22), one mechanism ...